Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11,…

Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Penny Stocks To Watch As Biotech Takes Center Stage In 2020

Biotech Penny Stocks To Watch This Month

Are These Penny Stocks On Your Biotech Watch List?

Biotech Penny Stocks To Watch This Week

Are Penny Stocks Part Of Your Investing Strategy? 4 To Watch

Do You Know How To Find The Best Penny Stocks Right Now?

Penny Stocks To Watch As Record COVID Cases Continue

Coronavirus Penny Stocks To Watch This Week

4 Penny Stocks To Watch If You’re Concerned About COVID

Are These On Your List Of Coronavirus Penny Stocks Right Now?

Penny Stocks To Watch Right Now After Record COVID Cases

Record Coronavirus Cases Trigger Momentum In Penny Stocks This Week

Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…